Cell Sciences' InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) is a Human monoclonal antibody. The InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) Antibody was generated using S as the antigen. It reacts with 2019-nCoV, Corona Virus, Coronavirus, COVID-19, SARS-CoV-2, and Virus. This antibody has been shown to work in applications such as: EIA, Immunoassay, In Vivo, Block/Neutralize/Inhibit, and ELISA.